Factors Associated with Drug Consumption Without Scientific Evidence in Patients with Mild COVID-19 in Peru.

• Autores: Soriano-Moreno, D.R., Fernandez-Guzman, D., Sangster-Carrasco, L., Quispe-Vicuña, C., Grados-Espinoza, P., Ccami-Bernal, F., Morocho-Alburqueque, N., Coba-Villan, N., Velasquez-Fernandez, R., Nieto- Gutierrez, W.
• Formato: artículo
• Fecha de Publicación: 2022
• Institución: Universidad Nacional de Cajamarca
• Repositorio: UNC-Institucional
• Lenguaje: inglés
• OAI Identifier: oai:repositorio.unc.edu.pe:20.500.14074/9521
• Enlace del recurso: http://hdl.handle.net/20.500.14074/9521; https:// doi.org/10.1097/PTS.0000000000001053
• Nivel de acceso: acceso abierto
• Materia: antibiotic; associated factors (source: MESH); COVID-19; drug therapy; ivermectin; SARS-CoV-2; https://purl.org/pe-repo/ocde/ford#3.03.05

Objective This study aimed to evaluate the factors associated with the consumption of drugs without scientific evidence in patients with mild COVID-19 infection in Peru. Methods An analytical cross-sectional study was carried out including 372 adult patients with a history of mild COVID-19 disease. Factors associated with drug consumption were evaluated by Poisson regressions with robust variance adjustment using the bootstrapping resampling method. Results Seventy-two percent consumed some medication without scientific evidence, with antibiotics (71%) and ivermectin for human use (68%) being the most commonly used. Factors associated with the consumption of drugs to treat mild COVID-19 infection were thinking that the drugs are not effective (adjusted prevalence ratio, 0.55; 95% confidence interval, 0.41-0.74) and not being informed about the efficacy of the drugs (adjusted prevalence ratio, 0.48; 95% confidence interval, 0.36-0.65). Conclusions Education of the population seems to be the main factor that increases the consumption of drugs without scientific evidence in the Peruvian population to treat mild COVID-19.